Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | PDE9A | O76083 | 1/20 | 0.33 |
| ▸ | BPTF | Q12830 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.32 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | PDE1A | P54750 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
| ▸ | COMT | P21964 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282462 | 0.77 | BRD9 (0.40) | CYP1A2LRRK2BPTFKAT2BCOMT | |
| SCHEMBL12411024 | 0.76 | BPTF (0.36) | CYP1A2PDE9ABPTFKAT2BPDE1A | |
| SCHEMBL9726422 | 0.73 | BPTF (0.40) | PDE9ABPTFKAT2BPDE1APDE1B | |
| SCHEMBL13843845 | 0.68 | CYP1A2 (0.40) | CYP1A2LRRK2 | |
| SCHEMBL7537868 | 0.67 | RAB9A (0.48) | CYP1A2ALDH1A1L3MBTL1 | |
| SCHEMBL16131353 | 0.67 | CYP1A2 (0.37) | CYP1A2LRRK2PDE9AACHEESR1 | |
| SCHEMBL9234085 | 0.67 | BPTF (0.48) | CYP1A2BPTFKAT2BALDH1A1 | |
| SCHEMBL18711605 | 0.66 | SPR (0.40) | CYP1A2LRRK2ACHEMAP3K12ESR1 | |
| SCHEMBL7600596 | 0.63 | GAA (0.37) | COMTL3MBTL1 | |
| SCHEMBL9726416 | 0.63 | ALDH1A1 (0.46) | CYP1A2BPTFKAT2BPDE1CALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634390-B2 | Agricultural chemicals | GLOBACHEM NV (BE) | 2023-04-25 | — | — | US | disclosed |
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | REDAG CROP PROT LTD (GB) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | CBR3, CBR1, CYP4X1 | CYP1A2 54/4885LRRK2 2696/4885PDE9A 2419/4885 |
| US-11634390-B2 | Agricultural chemicals | DDT, DHFR, AS3MT | CYP1A2 38/4885LRRK2 4163/4885PDE9A 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.